Bill Aurora, Pharm.D.

Dr. Bill Aurora is Chief Operating and Development Officer at Neumora and has held roles of increasing responsibility since joining the company in 2021. Prior to Neumora, Dr. Aurora held multiple roles including Chief Scientific Affairs Officer at Dermira, Inc, which was acquired by Eli Lilly in 2020. Previously, he held vice president roles in medical affairs at Neurocrine Biosciences from 2015 to 2016 as well as global scientific affairs at Merck Research Laboratories from 2014 to 2015 and various roles at Amgen from 2002 to 2014, most recently serving as Vice President, Global Scientific Affairs, Global Development and Vice President, Worldwide Compliance and Business Ethics. Dr. Aurora holds a B.S. in Pharmacy from the University of Texas at Austin and a Pharm.D. from the University of Texas Health Science Center, San Antonio, and obtained board certification in psychiatric pharmacy practice.